Delivery Order SPE2DB20D2104-SPE2DB24FU04N
- Not listed
- This federal contract award is for the delivery of Advair HFA 115-21 MCG Inhaler 12GM to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., as a firm fixed-price delivery order. The contract has a ceiling value of $3,853.72 and an ultimate completion date of February 27, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This federal contract award is for the delivery of Advair HFA 115-21 MCG Inhaler, 12GM, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for a ceiling value of $5,970.99. The contract is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for...
- This federal contract award is for the delivery of Advair HFA 230-21 MCG inhalers to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, through its Corporate Office division. The contract has a total ceiling value of $4,877.12 and is a firm fixed-price delivery order, with an ultimate completion date of June 4, 2024. The contract was awarded on June 3, 2024, and there...
- This federal contract award is for the delivery of Advair HFA 45-21 MCG inhalers to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 7, 2024, with a completion date of February 8, 2024. The contract has a ceiling value of $1,335.71 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which...
- This federal contract award is for the delivery of Advair HFA 115-21 MCG Inhaler 12GM to the Defense Logistics Agency (DLA). The contract has a ceiling value of $5,386.05 and is a firm fixed-price delivery order. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. This contract is not designated as a set-aside and was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This federal contract award is for the delivery of Advair HFA 115-21 MCG Inhaler, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,077.32 and is a delivery order with a firm fixed-price pricing type. The contract does not have a set-aside designation, indicating open competition....
- This federal contract award is for the delivery of Advair HFA 115-21 MCG Inhaler 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., has a ceiling value of $20,360.53 and runs through March 7, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating an open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This federal contract award is for the delivery of Advair HFA 115-21 MCG inhalers, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,774.71 and an ultimate completion date of February 21, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition....
- This federal contract award is for the delivery of Advair HFA 230-21 MCG Inhaler 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $15,046.11. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of May 30, 2024. The contract is not designated as a set-aside. Amerisourcebergen...
- The federal contract award is for the delivery of Advair HFA 230-21 MCG inhalers, with a ceiling value of $1,573.29. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. This contract is a delivery order, with a firm fixed-price pricing type, and does not have a set-aside designation. The period of performance runs from the award...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FU04NDelivery Order
This federal contract award is for the delivery of Advair HFA 115-21 MCG Inhaler 12GM to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor. The contract has a ceiling value of $5,776.91 and is a Firm Fixed Price Delivery Order with an ultimate completion date of May 7, 2024. The contract was awarded on May 6, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.8k | 5/6/24 |